Enhanced expression of CXCL1 in renal cell carcinoma facilitates tumor cell malignancy via PI3K/AKT‑dependent mechanisms

The expression of CXC motif chemokine ligand 1 (CXCL1) is elevated in numerous types of human cancers, and CXCL1 is also able to act as an autocrine/paracrine factor to accelerate the malignant progression of malignancies. However, at present, there is limited understanding of the role of CXCL1 in renal cell carcinoma (RCC). The present study aimed to investigate the mRNA and protein expression levels of CXCL1 in RCC tissues, which were found to be markedly elevated compared with normal and paracancerous tissues using bioinformatics and immunohistochemical analyses. In addition, high expression of CXCL1 was shown to be closely associated with higher stage, grade, tumor, lymph node and metastasis status of clear cell RCC, as well as with poor prognosis in patients. In addition, the expression level of CXCL1 mRNA was found to be associated with the expression of various tumor-associated genes, including numerous chemokines and their receptors, immune cell recruitment of B cells, CD4<sup>+</sup> T cells and neutrophils, as well as microsatellite instability in RCC. Functional studies were also performed, which demonstrated that both exogenous and overexpression of CXCL1 led to a marked enhancement of the proliferative and migratory capacities of RCC cells, whereas downregulation of CXCL1 exerted a suppressive influence on the malignant behaviors of the tumor cells. In addition, western blot analysis experiments revealed that overexpression of CXCL1 in RCC cells was able to regulate the expression levels of phosphoinositide 3-kinase (PI3K)/AKT pathway-associated proteins, including Bcl-2-associated X protein, B-cell lymphoma-2, PI3K and AKT. Finally, the AKT-specific inhibitor GDC-0068 was shown to reverse the promoting effects of CXCL1 on the malignant behaviors of RCC cells. Taken together, the findings of the present study have shown that CXCL1 exhibits high expression patterns in RCC tissues and may serve diverse functions in facilitating various aspects of RCC advancement.

Authors

Institutions

Publication Details

Journal
Oncology Letters
Published
2025-11-03
DOI
https://doi.org/10.3892/ol.2025.15372
Primary Topic
Chemokine receptors and signaling
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Enhanced expression of CXCL1 in renal cell carcinoma facilitates tumor cell malignancy via PI3K/AKT‑dependent mechanisms

Chen Liu, Yuhang Wang, Hongrui Zhang, H. Xiao et al.
Oncology Letters
Chemokine receptors and signaling
article

Enhanced expression of CXCL1 in renal cell carcinoma facilitates tumor cell malignancy via PI3K/AKT‑dependent mechanisms

Chen Liu, Yuhang Wang, Hongrui Zhang, H. Xiao, Hongbin Qiu, Baotian Wang, Shi-Liang Gui
article en

Abstract

The expression of CXC motif chemokine ligand 1 (CXCL1) is elevated in numerous types of human cancers, and CXCL1 is also able to act as an autocrine/paracrine factor to accelerate the malignant progression of malignancies. However, at present, there is limited understanding of the role of CXCL1 in renal cell carcinoma (RCC). The present study aimed to investigate the mRNA and protein expression levels of CXCL1 in RCC tissues, which were found to be markedly elevated compared with normal and paracancerous tissues using bioinformatics and immunohistochemical analyses. In addition, high expression of CXCL1 was shown to be closely associated with higher stage, grade, tumor, lymph node and metastasis status of clear cell RCC, as well as with poor prognosis in patients. In addition, the expression level of CXCL1 mRNA was found to be associated with the expression of various tumor-associated genes, including numerous chemokines and their receptors, immune cell recruitment of B cells, CD4<sup>+</sup> T cells and neutrophils, as well as microsatellite instability in RCC. Functional studies were also performed, which demonstrated that both exogenous and overexpression of CXCL1 led to a marked enhancement of the proliferative and migratory capacities of RCC cells, whereas downregulation of CXCL1 exerted a suppressive influence on the malignant behaviors of the tumor cells. In addition, western blot analysis experiments revealed that overexpression of CXCL1 in RCC cells was able to regulate the expression levels of phosphoinositide 3-kinase (PI3K)/AKT pathway-associated proteins, including Bcl-2-associated X protein, B-cell lymphoma-2, PI3K and AKT. Finally, the AKT-specific inhibitor GDC-0068 was shown to reverse the promoting effects of CXCL1 on the malignant behaviors of RCC cells. Taken together, the findings of the present study have shown that CXCL1 exhibits high expression patterns in RCC tissues and may serve diverse functions in facilitating various aspects of RCC advancement.

Oncology LettersVol. 31(1)
Jiamusi University (CN), First Affiliated Hospital of Jiamusi University (CN), Zhangzhou Vocational and Technical College (CN)
Openalex Percentile: Top 57%
Chemokine receptors and signaling
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.